ALFA FinderBSE filing, NSE: CGCL. Summary written from the filing by ALFA Finder's alert engine.
Capri Global Capital Ltd: key numbers
- Share price
- ₹246.27
- Market cap
- ₹23,695 Cr
- Revenue (annual)
- ₹4,731 Cr
- Net profit (annual)
- ₹949.1 Cr
- P/E (TTM)
- 18.1×Sector 21.0×
- Promoter holding
- 59.92%+0.00% QoQ
- FII holding
- 13.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capri Global Capital Ltd
All →Capri Global Capital Debt & Borrowing: ₹1.32 Cr
Capri Global paid Rs.1.32 Crore interest on its 9.75% Series 18 NCDs on the due date. The payment was certified under Reg 57 of LODR.
- Value
- ₹1.32 Cr
Capri Global Capital Debt & Borrowing: ₹10 Cr
Capri Global Capital redeemed 200 Commercial Papers at maturity on 13 Nov 2026. Principal of Rs.10 Crore was paid with no outstanding interest.
- Value
- ₹10.00 Cr
Capri Global Capital Debt & Borrowing: ₹3.87 Cr
Capri Global Capital Limited paid Rs.3.87 Crore quarterly interest on its 10.23% secured listed NCDs (Series 4) on 9 November 2026. The payment was made on the due date with no delay reported.
- Value
- ₹3.87 Cr
Capri Global Capital Debt & Borrowing: ₹282 Cr
Capri Global received NSE IFSC in-principle approval for up to USD 30 million senior secured bonds. Each bond has USD 10,000 face value.
- Value
- ₹282.0 Cr
Capri Global Capital Debt & Borrowing: ₹0.79 Cr
Capri Global paid Rs. 78.56 lakh interest on its 9.25% NCDs Series 13 ahead of the due date. The payment is certified under Regulation 57.
- Value
- ₹0.79 Cr
Capri Global Capital Debt & Borrowing: ₹50 Cr
Capri Global Capital redeemed ₹50 Crore of BSE-listed Commercial Paper at maturity on November 2, 2026. The filing confirms timely principal payment with NIL outstanding interest.
- Value
- ₹50.00 Cr
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr